EQL Pharma AB (publ) (STO:EQL)

EQL Pharma AB Revenue

EQL Pharma AB had revenue of 106.91M SEK in the quarter ending June 30, 2026, a decrease of -0.29%. This brings the company's total for the last twelve months to 432.36M, up 8.65% year-over-year. In the fiscal year ending March 31, 2026, EQL Pharma AB had annual revenue of 432.66M with 15.83% growth. That makes EQL Pharma AB the 28,844th largest company in the world by revenue and 371st in Sweden.

• Revenue (ttm): 432.36M
• Revenue Growth: +8.65%
• P/S Ratio: 1.63
• Revenue / Employee: 6.65M
• Employees: 65
• Market Cap: 671.80M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Denmark 162.14M 37.5%
• Sweden 144.66M 33.4%
• Other Europe 91.16M 21.1%
• Norway 21.03M 4.9%
• Finland 12.84M 3.0%
• Outside Europe 835.00K 0.2%

Fiscal year ended Mar 31, 2026 See the full EQL Pharma AB breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	432.66M	59.15M	15.83%
Mar 31, 2025	373.52M	109.35M	41.39%
Mar 31, 2024	264.17M	4.26M	1.64%
Mar 31, 2023	259.91M	-149.84M	-36.57%
Mar 31, 2022	409.75M	230.61M	128.73%
Mar 31, 2021	179.14M	107.11M	148.71%
Mar 31, 2020	72.03M	22.27M	44.77%
Mar 31, 2019	49.76M	21.17M	74.08%
Mar 31, 2018	28.58M	7.05M	32.72%
Dec 31, 2017	21.54M	-6.67M	-23.63%
Dec 31, 2016	28.20M	1.33M	4.94%
Dec 31, 2015	26.87M	9.28M	52.78%
Dec 31, 2014	17.59M	-4.58M	-20.67%
Dec 31, 2013	22.17M	5.50M	32.99%
Dec 31, 2012	16.67M	4.91M	41.69%
Dec 31, 2011	11.77M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Aug 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error